Ausdal Financial Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Ausdal Financial Partners's IBB Position: Q3 2026 in Review
Ausdal Financial Partners increased its iShares Biotechnology ETF (IBB) stake by 13% in Q3 2026, buying an estimated $42.1K and bringing the position to 1,837 shares worth $387K. The position accounts for 0.02% of the portfolio, ranked #731.
Ausdal Financial Partners first reported a position in IBB in Q4 2015 and has held it in 12 quarters since. The position peaked at $4.31M in Q3 2023. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Ausdal Financial Partners held 1,837 shares of iShares Biotechnology ETF worth $387K as of Q3 2026.
- Ausdal Financial Partners bought 210 iShares Biotechnology ETF shares in Q3 2026, an estimated $42.1K.
- iShares Biotechnology ETF made up 0.02% of Ausdal Financial Partners's portfolio in Q3 2026, its #731 holding.
- Ausdal Financial Partners first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 12 quarters since.
- Ausdal Financial Partners's iShares Biotechnology ETF position peaked at $4.31M in Q3 2023.
- 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Ausdal Financial Partners's 13F filing for Q3 2026, filed 16 Nov 2026.